SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-22-012462 to NYIAX, INC. (CIK 0001679379)

NYIAX, INC. (CIK 0001679379)
Date: Nov. 17, 2022 · CIK: 0001679379 · Accession: 0000000000-22-012462

AI Filing Summary & Sentiment

File numbers found in text: 333-265357

Date
November 17, 2022
Author
Office of Technology
Form
UPLOAD
Company
NYIAX, INC. (CIK 0001679379)

Letter

United States securities and exchange commission logo November 17, 2022 Christopher Hogan Interim Chief Executive Officer NYIAX, INC. 180 Maiden Lane, 11th Floor New York, NY 10005 Re:NYIAX, INC. Amendment No. 1 to Registration Statement on Form S-1 Filed October 20, 2022 File No. 333-265357 Dear Christopher Hogan: We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to these comments, we may have additional comments. Unless we note otherwise, our references to prior comments are to comments in our June 29, 2022 letter. Amendment No.1 to Registration Statement on Form S-1 Risk Factors, page 8 1.We note recent instances of extreme stock price run-ups followed by rapid price declines and stock price volatility seemingly unrelated to company performance following a number of recent initial public offerings, particularly among companies with relatively smaller public floats. Revise to include a separate risk factor addressing the potential for rapid and substantial price volatility and any known factors particular to your offering that may add to this risk and discuss the risks to investors when investing in stock where the price is changing rapidly. Clearly state that such volatility, including any stock-run up, may be unrelated to your actual or expected operating performance and financial condition or prospects, making it difficult for prospective investors to assess the rapidly

FirstName LastNameChristopher Hogan Comapany NameNYIAX, INC. November 17, 2022 Page 2 FirstName LastNameChristopher Hogan NYIAX, INC. November 17, 2022 Page 2 changing value of your stock. 2.In light of your commercial relationship with Nasdaq and the fact you intend to list your shares on the Nasdaq Capital Market, please consider including a risk factor discussing risks resulting from any conflicts of interest or the appearance of conflicts of interest. Management's Discussion and Analysis of Financial Condition and Results of Operations Results of Operations, page 30 3.In regard to your result of operations for the years ended December 31, 2021 and 2020, and elsewhere as appropriate, please label each column of the corrected financial statements as “restated.” Going Concern, Liquidity and Capital Resources, page 32 4.We note your response to prior comment 2. We also note your disclosure that management believes that the existing cash as of June 30, 2022 will not be sufficient to fund operations for at least the next 12 months. Please disclose the minimum number of months that you will be able to conduct your planned operations using currently available capital resources. Refer to Item 303(b)(1) and Section IV of SEC Release No. 33-8350 for additional guidance. Restatements, page 35 5.We note that your financial statements were restated. Please tell us whether a material weakness was identified, and if so, include a risk factor describing any material weaknesses, the resulting restatement, and any associated remediation procedures and the related time frame. General 6.Please tell us whether you are required to have a qualified independent underwriter in light of the potential conflicts of interest of your underwriter, West Park Capital, pursuant to FINRA Rule 5121. If so, please revise to add appropriate risk factor disclosure. You may contact Joseph Cascarano, Senior Staff Accountant, at 202-551-3376 or Lisa Etheredge, Senior Staff Accountant, at 202-551-3424 if you have questions regarding comments on the financial statements and related matters. Please contact Kyle Wiley, Staff Attorney, at 202-344-5791 or Mitchell Austin, Staff Attorney, at 202-551-3574 with any other questions.

FirstName LastNameChristopher Hogan Comapany NameNYIAX, INC. November 17, 2022 Page 3 FirstName LastName Christopher Hogan NYIAX, INC. November 17, 2022 Page 3 Sincerely, Division of Corporation Finance Office of Technology cc: Mitchell Lampert

Show Raw Text
United States securities and exchange commission logo
November 17, 2022
Christopher Hogan
Interim Chief Executive Officer
NYIAX, INC.
180 Maiden Lane, 11th Floor
New York, NY 10005
Re:NYIAX, INC.
Amendment No. 1 to Registration Statement on Form S-1
Filed October 20, 2022
File No. 333-265357
Dear Christopher Hogan:
            We have reviewed your amended registration statement and have the following
comments.  In some of our comments, we may ask you to provide us with information so we
may better understand your disclosure.
            Please respond to this letter by amending your registration statement and providing the
requested information.  If you do not believe our comments apply to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
            After reviewing any amendment to your registration statement and the information you
provide in response to these comments, we may have additional comments.  Unless we note
otherwise, our references to prior comments are to comments in our June 29, 2022 letter.
Amendment No.1 to Registration Statement on Form S-1
Risk Factors, page 8
1.We note recent instances of extreme stock price run-ups followed by rapid price declines
and stock price volatility seemingly unrelated to company performance following a
number of recent initial public offerings, particularly among companies with relatively
smaller public floats. Revise to include a separate risk factor addressing the potential for
rapid and substantial price volatility and any known factors particular to your offering that
may add to this risk and discuss the risks to investors when investing in stock where the
price is changing rapidly. Clearly state that such volatility, including any stock-run up,
may be unrelated to your actual or expected operating performance and financial
condition or prospects, making it difficult for prospective investors to assess the rapidly

 FirstName LastNameChristopher Hogan
 Comapany NameNYIAX, INC.
 November 17, 2022 Page 2
 FirstName LastNameChristopher Hogan
NYIAX, INC.
November 17, 2022
Page 2
changing value of your stock.
2.In light of your commercial relationship with Nasdaq and the fact you intend to list your
shares on the Nasdaq Capital Market, please consider including a risk factor discussing
risks resulting from any conflicts of interest or the appearance of conflicts of interest.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Results of Operations, page 30
3.In regard to your result of operations for the years ended December 31, 2021 and 2020,
and elsewhere as appropriate, please label each column of the corrected financial
statements as “restated.”
Going Concern, Liquidity and Capital Resources, page 32
4.We note your response to prior comment 2.  We also note your disclosure that
management believes that the existing cash as of June 30, 2022 will not be sufficient to
fund operations for at least the next 12 months. Please disclose the minimum number of
months that you will be able to conduct your planned operations using currently available
capital resources. Refer to Item 303(b)(1) and Section IV of SEC Release No. 33-8350 for
additional guidance.
Restatements, page 35
5.We note that your financial statements were restated.  Please tell us whether a material
weakness was identified, and if so, include a risk factor describing any material
weaknesses, the resulting restatement, and any associated remediation procedures and the
related time frame.
General
6.Please tell us whether you are required to have a qualified independent underwriter in
light of the potential conflicts of interest of your underwriter, West Park Capital, pursuant
to FINRA Rule 5121.  If so, please revise to add appropriate risk factor disclosure.
            You may contact Joseph Cascarano, Senior Staff Accountant, at 202-551-3376 or Lisa
Etheredge, Senior Staff Accountant, at 202-551-3424 if you have questions regarding comments
on the financial statements and related matters.  Please contact Kyle Wiley, Staff Attorney, at
202-344-5791 or Mitchell Austin, Staff Attorney, at 202-551-3574 with any other questions.

 FirstName LastNameChristopher Hogan
 Comapany NameNYIAX, INC.
 November 17, 2022 Page 3
 FirstName LastName
Christopher Hogan
NYIAX, INC.
November 17, 2022
Page 3
Sincerely,
Division of Corporation Finance
Office of Technology
cc:       Mitchell Lampert